H2BC21 and synovial sarcoma: To further evaluate the potential use of histones as early biomarkers for organ failure assessment, as well as their capability to predict the need of organ support therapies within the following 24 h, we analyzed H2B and H3 histone levels in SS patients requiring organ support therapy, specifically under RRT and IMV.